Neoadjuvant therapy affects tumor growth markers in early stage non-small-cell lung cancer

INTRODUCTION: While adjuvant therapy of early-stage non-small-cell lung cancer (NSCLC) is widely accepted, literature data concerning neoadjuvant treatment provide contradictory results with both improved and unaffected survival rates. Also, data concerning potential effects of neo-adjuvant therapy...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Chorostowska-Wynimko, J, Zaleska, J, Chabowski, M, Szpechcinski, A, Zych, J, Rudzinski, P, Langfort, R, Orlowski, T, Roszkowski-Sliz, K
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2009
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3521347/
https://ncbi.nlm.nih.gov/pubmed/20156723
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-14-S4-42
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky